Use of heme-peptides to prevent or retard disease associated with oxidative stress

US6013623A · kind A · utility

Assignee

• The Trustees of Columbia University in the City of New York · US

Inventors

• Abraham Spector · New York, US
• Wanchao Ma · New York, US
• Ren Wang · Beijing, CN

Key dates

• Filing date: Feb 27, 1997
• Grant date: Jan 11, 2000
• Expiry date: Feb 27, 2017

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K38/41
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

This invention provides a method for treating a condition associated with oxidative stress in a subject which comprises administering to the subject an amount of a heme-peptide effective to treat the condition associated with oxidative stress in the subject. The subject may be a mammal. The mammal may be a human being. The condition associated with oxidative stress may be an inflammatory condition, an allergic condition or an auto-immune condition.